Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 480 participants.
Also called NCT07932639
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 480 participants
- Registry
-
NCT07932639
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07932639. Randomized; single masking; primary purpose prevention. Start 2026-03-21 (actual); primary completion 2029-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis
- Acronym
- SPDACSIS-RCT
- Condition
- Ischemic Stroke
- Condition
- Symptomatic Intracranial Atherosclerotic Stenosis
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Second Affiliated Hospital of Soochow University
Record details
- Record id
cardio:ct-nct07932639- Content hash
537d16cb430a24c355195a5bdf222fc7d52430db8e3225e5bab047557cd431af